Discussion on the Inspiration for the Practice of Adverse Drug Reaction Monitoring in China by FDA “Sentinel Initiative”

Chinese Journal of Pharmacovigilance ›› 2011, Vol. 8 ›› Issue (5): 287-290.

Previous Articles Next Articles

Discussion on the Inspiration for the Practice of Adverse Drug Reaction Monitoring in China by FDA “Sentinel Initiative”

SHEN Lu

Center for Drug Reevaluation, Beijing 100045, China

Received:2011-03-14 Revised:2015-08-27 Online:2011-05-10 Published:2015-08-27

Abstract

CLC Number:

R954

SHEN Lu. Discussion on the Inspiration for the Practice of Adverse Drug Reaction Monitoring in China by FDA “Sentinel Initiative”[J]. Chinese Journal of Pharmacovigilance, 2011, 8(5): 287-290.

[1]	ZHENG Yi, LUO Xiao, ZHANG Pengpeng, LIU Yongmei, YE Xiaofei, GUO Xiaojing, CHEN Xia, HE Jia. Adverse reactions of immune checkpoint inhibitor myocarditis based on active monitoring system [J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 634-638.
[2]	ZHAO Yan, LI Dong, CHENG Yinjie, JIANG Bin, ZHAO Yifei, DONG Fang, YUAN Jing. Advances in studies on post-market safety data sources and signal detection for medical devices [J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 236-240.
[3]	WU Yunxiao, YU Yuelin, WANG Shengfeng, SUN Feng, MENG Ruogu, ZHAN Siyan. Suitability assessment of real-world data in active post-marketing surveillance of vaccine safety [J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1081-1089.
[4]	LIU Zhike, ZHAN Siyan. Progress in applications of self-controlled designs in association study of vaccine safety [J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 74-78.
[5]	SUN Yixin, LIU Zhike, ZHAN Siyan. Scoping review of near real-time surveillance of vaccine safety [J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 61-67.
[6]	HOU Yongfang, SONG Haibo, LIU Hongliang, LI Xilin. Practice and Discussion on Active Surveillance by China Hospital Pharmacovigilance System [J]. Chinese Journal of Pharmacovigilance, 2019, 16(4): 212-214.
[7]	WANG Meng, GUO Xiaojing, YE Xiaofei, XU Jinfang, HU Fangyuan, HE Jia. Application of Bayesian Instrumental Variable in Active Surveillance Data of Adverse Drug Reactions:a Simulation Study [J]. Chinese Journal of Pharmacovigilance, 2019, 16(3): 139-143.
[8]	WANG Linlin, YANG Yue, WANG Shuling. Application of the US FDA Sentinel System and Enlightenment [J]. Chinese Journal of Pharmacovigilance, 2019, 16(2): 81-87.
[9]	WU Jianru, XIAO Xiao, CHENG Bin, LIU Xiaoyu, WANG Ling, MAO Qiurong. Inspiration of Drug Abuse Surveillance and Warning System of USA to China [J]. Chinese Journal of Pharmacovigilance, 2019, 16(1): 32-36.
[10]	GUO Xiaojing, WANG Meng, GUO Wei, YE Xiaofei, ZHU Tiantian, HE Jia. Status and Challenges of Controlling Confounding Factors in Active Surveillance of Adverse Drug Reactions [J]. Chinese Journal of Pharmacovigilance, 2018, 15(10): 595-599.
[11]	CAI Ting, YANG Yu, WANG Ya-li, DONG Duo, ZHAN Si-yan. Review and Analysis of Active Post-marketing Surveillance Modes for Vaccine Safety [J]. Chinese Journal of Pharmacovigilance, 2017, 14(8): 464-469.
[12]	HOU Yong-fang, SHEN Lu, LIU Wei, SONG Hai-bo, LIU Cui-li, WANG Dan, LI Xin-ling. Medical Product Active Surveillance System in America and Its Revelation [J]. Chinese Journal of Pharmacovigilance, 2017, 14(1): 32-35.
[13]	SHEN Lu, LIU Wei, HOU Yong-fang, GUO Xue, PENG Li-li, KONG Fan-yao, LI Xin-ling. Ideas on the Project of Drug Safety Data Partner Cooperation in China [J]. Chinese Journal of Pharmacovigilance, 2016, 13(12): 737-739.
[14]	ZHANG Qian-ting, WANG Ya-li, QU Yi. Discussion on Vaccine Active Surveillance in China [J]. Chinese Journal of Pharmacovigilance, 2016, 13(11): 673-675.
[15]	WANG Ling. Study on Application of Data Organization and Common Data Model of the Observational Medical Outcomes Partnership in US [J]. Chinese Journal of Pharmacovigilance, 2015, 12(6): 341-346.

Discussion on the Inspiration for the Practice of Adverse Drug Reaction Monitoring in China by FDA “Sentinel Initiative”

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics